Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation
The objectives of this study were to evaluate when patients received MMR vaccine after an HSCT in our care service and if there were reports of any side effects. We retrospectively reviewed the records of HSCT recipients who received at least one MMR dose in our care service, a quaternary teaching hospital in Sao Paulo city, Brazil, from 2017 to 2021. We identified 82 patients: 75.6% (90.1% in the autologous group and 45.1% in the allogeneic group) were vaccinated before 23 months post-transplantation. None reported side effects following the vaccination. Our data support that the MMR vaccination is safe from 12 to 23 mont...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 22, 2023 Category: Tropical Medicine Authors: Bruno Azevedo Randi Eder Gatti Fernandes Hermes Ryoiti Higashino Marta Heloisa Lopes Vanderson Geraldo Rocha Silvia Figueiredo Costa Ana Marli Christovam Sartori Source Type: research
